D. Koulenti, E. Tsigou, and J. Rello, Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study, European Journal of Clinical Microbiology & Infectious Diseases, vol.80, issue.7???8, 2016.
DOI : 10.1016/j.jhin.2011.11.014

K. Giuliano, D. Baker, and B. Quinn, The epidemiology of non-ventilator hospitalacquired pneumonia in the United States, Am J Infect Control, vol.pii, issue.17, pp.196-655331056, 2017.

W. Melsen, M. Rovers, R. Groenwold, D. Bergmans, C. Camus et al., Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies, The Lancet Infectious Diseases, vol.13, issue.8, pp.665-71, 2013.
DOI : 10.1016/S1473-3099(13)70081-1

W. Branch-elliman, S. Wright, and M. Howell, Determining the Ideal Strategy for Ventilator-associated Pneumonia Prevention. Cost???Benefit Analysis, American Journal of Respiratory and Critical Care Medicine, vol.7, issue.1, pp.57-63, 2015.
DOI : 10.1513/AnnalsATS.201405-201CME

M. Niederman, Hospital???Acquired Pneumonia, Health Care???Associated Pneumonia, Ventilator???Associated Pneumonia, and Ventilator???Associated Tracheobronchitis: Definitions and Challenges in Trial Design, Clinical Infectious Diseases, vol.51, issue.S1, pp.12-19, 2010.
DOI : 10.1086/653035

M. Zwarenstein, J. Goldman, and S. Reeves, Interprofessional collaboration: effects of practice-based interventions on professional practice and healthcare outcomes, Cochrane Database Syst Rev, vol.18, issue.8, p.72, 2009.
DOI : 10.1186/1745-6215-8-23

R. Ferrer, A. Artigas, M. Levy, J. Blanco, G. Gonzá-lez-díaz et al., Improvement in Process of Care and Outcome After a Multicenter Severe Sepsis Educational Program in Spain, JAMA, vol.299, issue.19, pp.2294-303, 2008.
DOI : 10.1001/jama.299.19.2294

M. Klompas, L. Li, K. Kleinman, P. Szumita, and A. Massaro, Associations Between Ventilator Bundle Components and Outcomes, JAMA Internal Medicine, vol.176, issue.9, pp.1277-83, 2016.
DOI : 10.1001/jamainternmed.2016.2427

D. Leisman, M. Doerfler, M. Ward, K. Masick, B. Wie et al., Survival Benefit and Cost Savings From Compliance With a Simplified 3-Hour Sepsis Bundle in a Series of Prospective, Multisite, Observational Cohorts, Critical Care Medicine, vol.45, issue.3, pp.395-406, 2017.
DOI : 10.1097/CCM.0000000000002184

C. Lilly, S. Cody, H. Zhao, K. Landry, S. Baker et al., Hospital Mortality, Length of Stay, and Preventable Complications Among Critically Ill Patients Before and After Tele-ICU Reengineering of Critical Care Processes, JAMA, vol.305, issue.21, pp.2175-83, 2011.
DOI : 10.1001/jama.2011.697

L. Bouadma, E. Deslandes, I. Lolom, L. Corre, B. Mourvillier et al., Long???Term Impact of a Multifaceted Prevention Program on Ventilator???Associated Pneumonia in a Medical Intensive Care Unit, Clinical Infectious Diseases, vol.51, issue.10, pp.1115-1137, 2010.
DOI : 10.1086/656737

A. Roquilly, R. Cinotti, S. Jaber, M. Vourc-'h, F. Pengam et al., Implementation of an Evidence-based Extubation Readiness Bundle in 499 Brain-injured Patients. A Before???After Evaluation of a Quality Improvement Project, American Journal of Respiratory and Critical Care Medicine, vol.75, issue.8, pp.958-66, 2013.
DOI : 10.1007/s00134-009-1717-8
URL : https://hal.archives-ouvertes.fr/hal-01857716

S. Nseir, D. Pompeo, C. Soubrier, S. Cavestri, B. Jozefowicz et al., Impact of Ventilator-Associated Pneumonia on Outcome in Patients With COPD, Chest, vol.128, issue.3, pp.1650-1656, 2005.
DOI : 10.1378/chest.128.3.1650

M. Bigham, R. Amato, P. Bondurrant, J. Fridriksson, C. Krawczeski et al., Ventilator-Associated Pneumonia in the Pediatric Intensive Care Unit: Characterizing the Problem and Implementing a Sustainable Solution, The Journal of Pediatrics, vol.154, issue.4, pp.582-589, 2009.
DOI : 10.1016/j.jpeds.2008.10.019

A. Cheema, A. Scott, K. Shambaugh, J. Shaffer-hartman, R. Dechert et al., Rebound in ventilator-associated pneumonia rates during a prevention checklist washout period, BMJ Quality & Safety, vol.20, issue.9, pp.811-818, 2011.
DOI : 10.1136/bmjqs.2011.051243

J. Morinec, J. Iacaboni, and M. Mcnett, Risk Factors and Interventions for Ventilator-Associated Pneumonia in Pediatric Patients, Journal of Pediatric Nursing, vol.27, issue.5, pp.435-477, 2012.
DOI : 10.1016/j.pedn.2012.03.027

J. Brierley, L. Highe, S. Hines, and G. Dixon, Reducing VAP by instituting a care bundle using improvement methodology in a UK Paediatric Intensive Care Unit, European Journal of Pediatrics, vol.17, issue.8, pp.323-353, 2012.
DOI : 10.1053/j.spid.2006.04.003

V. Rosenthal, M. Rodríguez-calderó-n, M. Rodríguez-ferrer, T. Singhal, M. Pawar et al., Conclusions., Infection Control & Hospital Epidemiology, vol.33, issue.07, pp.704-714, 2012.
DOI : 10.1086/502291

A. Gupta, A. Kapil, S. Kabra, R. Lodha, S. Sood et al., Assessing the impact of an educational intervention on ventilator-associated pneumonia in a pediatric critical care unit, American Journal of Infection Control, vol.42, issue.2, pp.111-116, 2014.
DOI : 10.1016/j.ajic.2013.09.026

D. Cristofano, A. Peuchot, V. Canepari, A. Franco, V. Perez et al., Implementation of a Ventilator-Associated Pneumonia Prevention Bundle in a Single PICU*, Pediatric Critical Care Medicine, vol.17, issue.5, pp.451-457, 2016.
DOI : 10.1097/PCC.0000000000000714

Y. Peñ-a-ló-pez, M. Pujol, M. Campins, A. Gonzá-lez-antelo, J. Rodrigo et al., Implementing a care bundle approach reduces ventilator-associated pneumonia and delays ventilator-associated tracheobronchitis in children: differences according to endotracheal or tracheostomy devices, International Journal of Infectious Diseases, vol.52, pp.43-51, 2016.
DOI : 10.1016/j.ijid.2016.09.021

A. Liberati, D. Amico, R. Pifferi, S. Torri, V. Brazzi et al., Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care, Cochrane Database Syst Rev, vol.307, p.22, 2009.
DOI : 10.1136/bmj.307.6903.525

W. Melsen, A. De-smet, J. Kluytmans, M. Bonten, S. Dutch et al., Selective decontamination of the oral and digestive tract in surgical versus non-surgical patients in intensive care in a cluster-randomized trial, British Journal of Surgery, vol.11, issue.2
DOI : 10.1016/S1473-3099(11)70035-4

, Br J Surg, vol.99, issue.2, pp.232-239, 2012.

A. Roquilly, E. Marret, E. Abraham, and K. Asehnoune, Pneumonia Prevention to Decrease Mortality in Intensive Care Unit: A Systematic Review and Meta-analysis, Clinical Infectious Diseases, vol.182, issue.suppl A, pp.64-75, 2015.
DOI : 10.1164/rccm.201001-0094OC

A. Smet, J. Kluytmans, B. Cooper, E. Mascini, R. Benus et al., Decontamination of the Digestive Tract and Oropharynx in ICU Patients, New England Journal of Medicine, vol.360, issue.1, pp.20-31, 2009.
DOI : 10.1056/NEJMoa0800394

N. Daneman, S. Sarwar, R. Fowler, and B. Cuthbertson, Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis, The Lancet Infectious Diseases, vol.13, issue.4, pp.328-369, 2013.
DOI : 10.1016/S1473-3099(12)70322-5

A. Roquilly, F. Feuillet, P. Seguin, S. Lasocki, R. Cinotti et al., Empiric antimicrobial therapy for ventilator-associated pneumonia after brain injury, European Respiratory Journal, vol.47, issue.4, pp.1219-1247, 2016.
DOI : 10.1183/13993003.01314-2015
URL : https://hal.archives-ouvertes.fr/hal-01259226

L. Cabrini, G. Landoni, A. Oriani, V. Plumari, L. Nobile et al., Noninvasive Ventilation and Survival in Acute Care Settings, Critical Care Medicine, vol.43, issue.4, pp.880-888, 2015.
DOI : 10.1097/CCM.0000000000000819

S. Jaber, T. Lescot, E. Futier, C. Paugam-burtz, P. Seguin et al., Effect of Noninvasive Ventilation on Tracheal Reintubation Among Patients With Hypoxemic Respiratory Failure Following Abdominal Surgery, JAMA, vol.315, issue.13, pp.1345-53, 2016.
DOI : 10.1001/jama.2016.2706
URL : https://hal.archives-ouvertes.fr/hal-01305486

K. Burns, M. Meade, A. Premji, and N. Adhikari, Noninvasive ventilation as a weaning strategy for mechanical ventilation in adults with respiratory failure: a Cochrane systematic review, Canadian Medical Association Journal, vol.186, issue.3, pp.112-134, 2014.
DOI : 10.1503/cmaj.130974

L. Peng, P. Ren, X. Liu, C. Zhang, H. Zuo et al., Use of noninvasive ventilation at the pulmonary infection control window for acute respiratory failure in AECOPD patients, Medicine, vol.95, issue.24, p.3880, 2016.
DOI : 10.1097/MD.0000000000003880

J. Quenot, S. Ladoire, F. Devoucoux, J. Doise, R. Cailliod et al., Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumonia*, Critical Care Medicine, vol.35, issue.9, pp.2031-2037, 2007.
DOI : 10.1097/01.ccm.0000282733.83089.4d

B. De-jonghe, S. Bastuji-garin, P. Fangio, and J. Lacherade,

C. Vecchi, Sedation algorithm in critically ill patients without acute brain injury, Crit Care Med, vol.33, issue.1, pp.120-127, 2005.

P. Marik and G. Zaloga, Early enteral nutrition in acutely ill patients: A systematic review, Critical Care Medicine, vol.29, issue.12, pp.2264-70, 2001.
DOI : 10.1097/00003246-200112000-00005

G. Doig, P. Heighes, F. Simpson, E. Sweetman, and A. Davies, Early enteral nutrition, provided within 24??h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials, Intensive Care Medicine, vol.12, issue.12, pp.2018-2045, 2009.
DOI : 10.1001/archsurg.1986.01400020082010

R. Blaser, A. Starkopf, J. Alhazzani, W. Berger, M. Casaer et al., Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines, Intensive Care Medicine, vol.27, issue.6 Suppl 1, pp.380-98, 2017.
DOI : 10.1097/00003246-199908000-00006

L. Lorente, M. Lecuona, A. Jimé-nez, L. Lorenzo, I. Roca et al., Continuous endotracheal tube cuff pressure control system protects against ventilator-associated pneumonia, Critical Care, vol.18, issue.2, p.77, 2014.
DOI : 10.1183/09031936.00048507

M. Valencia, M. Ferrer, R. Farre, D. Navajas, J. Badia et al., Automatic control of tracheal tube cuff pressure in ventilated patients in semirecumbent position: A randomized trial*, Critical Care Medicine, vol.35, issue.6, pp.1543-1552, 2007.
DOI : 10.1097/01.CCM.0000266686.95843.7D

S. Nseir, F. Zerimech, C. Fournier, R. Lubret, P. Ramon et al., Continuous Control of Tracheal Cuff Pressure and Microaspiration of Gastric Contents in Critically Ill Patients, American Journal of Respiratory and Critical Care Medicine, vol.183, issue.9, pp.1041-1048, 2011.
DOI : 10.1007/s00134-010-1984-4

D. Caroff, L. Li, J. Muscedere, and M. Klompas, Subglottic Secretion Drainage and Objective Outcomes, Critical Care Medicine, vol.44, issue.4, pp.830-870, 2016.
DOI : 10.1097/CCM.0000000000001414

J. Muscedere, O. Rewa, K. Mckechnie, X. Jiang, D. Laporta et al., Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: A systematic review and meta-analysis*, Critical Care Medicine, vol.39, issue.8, pp.1985-91, 2011.
DOI : 10.1097/CCM.0b013e318218a4d9

L. Holzapfel, C. Chastang, G. Demingeon, J. Bohe, B. Piralla et al., A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia

, Am J Respir Crit Care Med, vol.159, issue.3, pp.695-701, 1999.

I. Siempos, T. Ntaidou, F. Filippidis, and A. Choi, Effect of early versus late or no tracheostomy on mortality and pneumonia of critically ill patients receiving mechanical ventilation: a systematic review and meta-analysis, The Lancet Respiratory Medicine, vol.3, issue.2, pp.150-158, 2015.
DOI : 10.1016/S2213-2600(15)00007-7

D. Young, D. Harrison, B. Cuthbertson, and K. Rowan, Effect of Early vs Late Tracheostomy Placement on Survival in Patients Receiving Mechanical Ventilation, JAMA, vol.309, issue.20, pp.2121-2130, 2013.
DOI : 10.1001/jama.2013.5154

P. Seguin, B. Laviolle, C. Dahyot-fizelier, R. Dumont, B. Veber et al., Effect of Oropharyngeal Povidone-Iodine Preventive Oral Care on Ventilator-Associated Pneumonia in Severely Brain-Injured or Cerebral Hemorrhage Patients, Critical Care Medicine, vol.42, issue.1, pp.1-8, 2014.
DOI : 10.1097/CCM.0b013e3182a2770f
URL : https://hal.archives-ouvertes.fr/hal-00933163

M. Krag, A. Perner, J. Wetterslev, M. Wise, H. Møller et al., Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients, Intensive Care Medicine, vol.107, issue.4, pp.11-22, 2014.
DOI : 10.1038/ajg.2011.474

S. Alkhawaja, C. Martin, R. Butler, and F. Gwadry-sridhar, Post-pyloric versus gastric tube feeding for preventing pneumonia and improving nutritional outcomes in critically ill adults, Cochrane Database Syst Rev, vol.8, p.8875, 2015.

W. Manzanares, M. Lemieux, P. Langlois, and P. Wischmeyer, Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis, Crit Care, vol.19, p.262, 2016.

L. Bo, J. Li, T. Tao, Y. Bai, X. Ye et al., Probiotics for preventing ventilator-associated pneumonia, Cochrane Database Syst Rev, vol.10, p.9066, 2014.

J. Wang, K. Liu, F. Ariani, L. Tao, J. Zhang et al., Probiotics for Preventing Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials, PLoS ONE, vol.265, issue.12, p.83934, 2013.
DOI : 10.1371/journal.pone.0083934.s001

I. Siempos, K. Vardakas, and M. Falagas, Closed tracheal suction systems for prevention of ventilator-associated pneumonia, British Journal of Anaesthesia, vol.100, issue.3, pp.299-306, 2008.
DOI : 10.1093/bja/aem403

G. Tokmaji, H. Vermeulen, M. Mü-ller, P. Kwakman, M. Schultz et al., Silver-coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patients, Cochrane Database Syst Rev, vol.8, p.9201, 2015.

F. Philippart, S. Gaudry, L. Quinquis, N. Lau, I. Ouanes et al., Randomized Intubation with Polyurethane or Conical Cuffs to Prevent Pneumonia in Ventilated Patients, American Journal of Respiratory and Critical Care Medicine, vol.40, issue.6, pp.637-682, 2015.
DOI : 10.1016/j.jinf.2012.06.016

M. Kelly, D. Gillies, D. Todd, and C. Lockwood, Heated humidification versus heat and moisture exchangers for ventilated adults and children, Cochrane Database Syst Rev, issue.4, p.4711, 2010.
DOI : 10.1002/14651858.cd004711

M. Menegueti, M. Auxiliadora-martins, and A. Nunes, Effectiveness of heat and moisture exchangers in preventing ventilator-associated pneumonia in critically ill patients: a meta-analysis, BMC Anesthesiology, vol.30, issue.6, p.115, 2014.
DOI : 10.1097/00003246-200201000-00033

M. Noto, H. Domenico, D. Byrne, T. Talbot, T. Rice et al., Chlorhexidine Bathing and Health Care???Associated Infections, JAMA, vol.313, issue.4, pp.369-78, 2015.
DOI : 10.1001/jama.2014.18400
URL : https://jamanetwork.com/journals/jama/articlepdf/2091544/joi140179.pdf

J. Swan, C. Ashton, L. Bui, V. Pham, B. Shirkey et al., Effect of Chlorhexidine Bathing Every Other Day on Prevention of Hospital-Acquired Infections in the Surgical ICU, Critical Care Medicine, vol.44, issue.10, pp.1822-1854, 2016.
DOI : 10.1097/CCM.0000000000001820

J. Pugin, R. Auckenthaler, N. Mili, J. Janssens, P. Lew et al., Diagnosis of Ventilator-associated Pneumonia by Bacteriologic Analysis of Bronchoscopic and Nonbronchoscopic ???Blind??? Bronchoalveolar Lavage Fluid, American Review of Respiratory Disease, vol.17, issue.5_pt_1, pp.1121-1130, 1991.
DOI : 10.1164/ajrccm/137.2.253

L. Papazian, P. Thomas, L. Garbe, I. Guignon, X. Thirion et al., Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia., American Journal of Respiratory and Critical Care Medicine, vol.152, issue.6, pp.1982-91, 1995.
DOI : 10.1164/ajrccm.152.6.8520766

M. Fartoukh, B. Maitre, S. Honoré, C. Cerf, J. Zahar et al., Diagnosing Pneumonia during Mechanical Ventilation, American Journal of Respiratory and Critical Care Medicine, vol.168, issue.2, pp.173-182, 2003.
DOI : 10.1055/s-2002-35717

C. Schurink, C. Van-nieuwenhoven, J. Jacobs, M. Rozenberg-arska, H. Joore et al., Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter-observer variability, Intensive Care Medicine, vol.265, issue.2, pp.217-241, 2004.
DOI : 10.1001/jama.1991.03460200084041

N. Fà-bregas, S. Ewig, A. Torres, M. El-ebiary, J. Ramirez et al., Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies, Thorax, vol.54, issue.10, pp.867-73, 1999.
DOI : 10.1136/thx.54.10.867

F. Lauzier, A. Ruest, D. Cook, P. Dodek, M. Albert et al., The value of pretest probability and modified clinical pulmonary infection score to diagnose ventilator-associated pneumonia, Journal of Critical Care, vol.23, issue.1, pp.50-57, 2008.
DOI : 10.1016/j.jcrc.2008.01.006

C. Luna, D. Blanzaco, M. Niederman, W. Matarucco, N. Baredes et al., Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome*, Critical Care Medicine, vol.31, issue.3, pp.676-82, 2003.
DOI : 10.1097/01.CCM.0000055380.86458.1E

N. Singh, P. Rogers, C. Atwood, M. Wagener, and V. Yu, Short-course Empiric Antibiotic Therapy for Patients with Pulmonary Infiltrates in the Intensive Care Unit, American Journal of Respiratory and Critical Care Medicine, vol.11, issue.2, pp.505-516, 2000.
DOI : 10.1093/clinids/24.2.211

C. Luyt, J. Chastre, and J. Fagon, Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia, Intensive Care Medicine, vol.30, issue.5, pp.844-52, 2004.
DOI : 10.1007/s00134-003-2125-0

J. Larsson, T. Itenov, and M. Bestle, Risk prediction models for mortality in patients with ventilator-associated pneumonia: A systematic review and meta-analysis, Journal of Critical Care, vol.37, pp.112-120, 2017.
DOI : 10.1016/j.jcrc.2016.09.003

D. Berton, A. Kalil, and P. Teixeira, Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilatorassociated pneumonia, Cochrane Database Syst Rev, issue.10, p.6482, 2014.

J. Fagon, J. Chastre, M. Wolff, C. Gervais, S. Parer-aubas et al., Invasive and Noninvasive Strategies for Management of Suspected Ventilator-Associated Pneumonia, Annals of Internal Medicine, vol.132, issue.8, pp.621-651, 2000.
DOI : 10.7326/0003-4819-132-8-200004180-00004

A. Kalil, M. Metersky, M. Klompas, J. Muscedere, D. Sweeney et al., Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society, Clinical Infectious Diseases, vol.63, issue.5, pp.575-82, 2016.
DOI : 10.1179/joc.2005.17.6.622

M. Klompas, Does This Patient Have Ventilator-Associated Pneumonia?, JAMA, vol.297, issue.14, pp.1583-93, 2007.
DOI : 10.1001/jama.297.14.1583

A. Contejean, V. Lemiale, M. Resche-rigon, D. Mokart, F. Pè-ne et al., Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en R??animation Respiratoire en Onco-H??matologie (Grrr-OH) study, Annals of Intensive Care, vol.7, issue.1, p.102, 2016.
DOI : 10.1183/09031936.94.07010114

E. Azoulay, D. Mokart, A. Rabbat, F. Pene, A. Kouatchet et al., Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: Prospective multicenter data*, Critical Care Medicine, vol.36, issue.1, pp.100-107, 2008.
DOI : 10.1097/01.CCM.0000295590.33145.C4

E. Azoulay, D. Mokart, J. Lambert, V. Lemiale, A. Rabbat et al., Diagnostic Strategy for Hematology and Oncology Patients with Acute Respiratory Failure, American Journal of Respiratory and Critical Care Medicine, vol.182, issue.8, pp.1038-1084, 2010.
DOI : 10.1086/518873

M. Labenne, C. Poyart, C. Rambaud, B. Goldfarb, B. Pron et al., Blind protected specimen brush and bronchoalveolar lavage in ventilated children, Critical Care Medicine, vol.27, issue.11, pp.2537-2580, 1999.
DOI : 10.1097/00003246-199911000-00035

F. Gauvin, C. Dassa, M. Cha?¨boucha?¨bou, F. Proulx, C. Farrell et al., Ventilator-associated pneumonia in intubated children: Comparison of different diagnostic methods*, Pediatric Critical Care Medicine, vol.4, issue.4, pp.437-480, 2003.
DOI : 10.1097/01.PCC.0000090290.53959.F4

A. Sachdev, K. Chugh, M. Sethi, D. Gupta, C. Wattal et al., Diagnosis of ventilator-associated pneumonia in children in resource-limited setting: A comparative study of bronchoscopic and nonbronchoscopic methods*, Pediatric Critical Care Medicine, vol.11, issue.2, pp.258-66, 2010.
DOI : 10.1097/PCC.0b013e3181bc5b00

A. Sachdev, K. Chugh, V. Raghunathan, D. Gupta, C. Wattal et al., Diagnosis of Bacterial Ventilator???Associated Pneumonia in Children, Pediatric Critical Care Medicine, vol.14, issue.1, pp.1-7, 2013.
DOI : 10.1097/PCC.0b013e318260129d

D. Willson, M. Conaway, R. Kelly, and J. Hendley, The Lack of Specificity of Tracheal Aspirates in the Diagnosis of Pulmonary Infection in Intubated Children, Pediatric Critical Care Medicine, vol.15, issue.4, pp.299-305, 2014.
DOI : 10.1097/PCC.0000000000000106

P. Ramirez, M. Garcia, M. Ferrer, J. Aznar, M. Valencia et al., Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia, European Respiratory Journal, vol.31, issue.2, pp.356-62, 2008.
DOI : 10.1183/09031936.00086707

C. Luyt, A. Combes, C. Reynaud, G. Hekimian, A. Nieszkowska et al., Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia, Intensive Care Medicine, vol.131, issue.8, pp.1434-1474, 2008.
DOI : 10.1164/ajrccm.150.3.8087341

P. Charles, E. Kus, S. Aho, S. Prin, J. Doise et al., Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report, BMC Infectious Diseases, vol.30, issue.1, p.49, 2009.
DOI : 10.1007/s00134-003-2125-0

B. Jung, N. Embriaco, F. Roux, J. Forel, D. Demory et al., Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score, Intensive Care Medicine, vol.31, issue.5, pp.790-798, 2010.
DOI : 10.1097/00003246-199811000-00016

J. Dallas, S. Brown, K. Hock, M. Scott, L. Skrupky et al., Diagnostic Utility of Plasma Procalcitonin for Nosocomial Pneumonia in the Intensive Care Unit Setting, Respiratory Care, vol.56, issue.4, pp.412-421, 2011.
DOI : 10.4187/respcare.00979

L. Su, K. Meng, X. Zhang, H. Wang, P. Yan et al., Diagnosing Ventilator-Associated Pneumonia in Critically Ill Patients With Sepsis, American Journal of Critical Care, vol.21, issue.6, pp.110-119, 2012.
DOI : 10.4037/ajcc2012732

S. Habib, A. Mukhtar, H. Abdelreheem, M. Khorshied, R. Sayed et al., Conclusions:, Clinical Chemistry and Laboratory Medicine (CCLM), vol.14, issue.5, pp.889-95, 2016.
DOI : 10.1097/MCP.0b013e3282f76457

S. Gibot, A. Cravoisy, R. Dupays, D. Barraud, L. Nace et al., Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis, Scandinavian Journal of Infectious Diseases, vol.18, issue.6-7, pp.6-7604, 2007.
DOI : 10.1157/13086523

S. Gibot, A. Cravoisy, B. Levy, M. Bene, G. Faure et al., Soluble Triggering Receptor Expressed on Myeloid Cells and the Diagnosis of Pneumonia, New England Journal of Medicine, vol.350, issue.5, pp.451-459, 2004.
DOI : 10.1056/NEJMoa031544

R. Determann, J. Millo, S. Gibot, J. Korevaar, M. Vroom et al., Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia, Intensive Care Medicine, vol.127, issue.11, pp.1495-500, 2005.
DOI : 10.1164/ajrccm.152.6.8520742

G. Horonenko, J. Hoyt, R. Robbins, C. Singarajah, A. Umar et al., Soluble Triggering Receptor Expressed on Myeloid Cell-1 Is Increased in Patients With Ventilator-Associated Pneumonia, Chest, vol.132, issue.1, pp.58-63, 2007.
DOI : 10.1378/chest.06-2731

N. Anand, S. Zuick, J. Klesney-tait, and M. Kollef, Diagnostic Implications of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in BAL Fluid of Patients With Pulmonary Infiltrates in the ICU, Chest, vol.135, issue.3, pp.641-648, 2009.
DOI : 10.1378/chest.08-1829

S. Palazzo, T. Simpson, J. Simmons, and L. Schnapp, Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as a diagnostic marker of ventilatorassociated pneumonia, Respir Care, vol.57, issue.12, pp.2052-2060, 2012.

P. Ramirez, P. Kot, V. Marti, M. Gomez, R. Martinez et al., Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in patients with acute respiratory distress syndrome and abdominal diseases: a preliminary observational study, Critical Care, vol.15, issue.1, p.50, 2011.
DOI : 10.1186/cc10015

H. Dupont, H. Mentec, J. Sollet, and G. Bleichner, Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia, Intensive Care Medicine, vol.27, issue.2, pp.355-62, 2001.
DOI : 10.1007/s001340000640

P. Teixeira, R. Seligman, F. Hertz, D. Cruz, and J. Fachel, Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes, Journal of Hospital Infection, vol.65, issue.4, pp.361-368, 2007.
DOI : 10.1016/j.jhin.2006.12.019

M. Leone, F. Garcin, J. Bouvenot, I. Boyadjev, P. Visintini et al., Ventilator-associated pneumonia: Breaking the vicious circle of antibiotic overuse*, Critical Care Medicine, vol.35, issue.2, pp.379-85, 2007.
DOI : 10.1097/01.CCM.0000253404.69418.AA

O. Leroy, T. Escrivan, P. Devos, L. Dubreuil, E. Kipnis et al., Hospital-Acquired Pneumonia in Critically Ill Patients: Factors Associated with Episodes Due to Imipenem-Resistant Organisms, Infection, vol.33, issue.3, pp.129-164, 2005.
DOI : 10.1007/s15010-005-4021-8

J. Muscedere, A. Shorr, X. Jiang, A. Day, and D. Heyland, Canadian Critical Care Trials Group. The adequacy of timely empiric antibiotic therapy for ventilator-associated pneumonia: an important determinant of outcome, J Crit Care, vol.27, issue.3, pp.322-329, 2012.

E. Kuti, A. Patel, and C. Coleman, Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: A meta-analysis, Journal of Critical Care, vol.23, issue.1, pp.91-100, 2008.
DOI : 10.1016/j.jcrc.2007.08.007

S. Awad, A. Rodriguez, Y. Chuang, Z. Marjanek, A. Pareigis et al., A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia, Clinical Infectious Diseases, vol.57, issue.5, pp.51-61, 2014.
DOI : 10.1128/AAC.02292-12

P. Damas, C. Garweg, M. Monchi, M. Nys, J. Canivet et al., Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia, Critical Care, vol.10, issue.2, p.52, 2006.
DOI : 10.1186/cc4879

D. Heyland, P. Dodek, J. Muscedere, A. Day, and D. Cook, Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia*, Critical Care Medicine, vol.36, issue.3, pp.737-781, 2008.
DOI : 10.1097/01.CCM.0B013E31816203D6

L. Arthur, R. Kizor, A. Selim, M. Van-driel, and L. Seoane, Antibiotics for ventilator-associated pneumonia, Cochrane Database of Systematic Reviews, vol.25, issue.4, p.4267, 2016.
DOI : 10.1002/14651858.CD004267.pub3

A. Lerma and F. , Efficacy of Meropenem as Monotherapy in the Treatment of Ventilator-Associated Pneumonia, Journal of Chemotherapy, vol.26, issue.25, pp.70-81, 2001.
DOI : 10.1378/chest.101.1.194

M. Paul, V. Shani, E. Muchtar, G. Kariv, E. Robenshtok et al., Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis, Antimicrobial Agents and Chemotherapy, vol.54, issue.11, pp.4851-63, 2010.
DOI : 10.1128/AAC.00627-10

J. Swanson and D. Wells, Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia, Antibiotics, vol.250, issue.3, pp.339-51
DOI : 10.1128/JCM.02409-12

J. Garnacho-montero, M. Sa-borges, J. Sole-violan, F. Barcenilla, A. Escoresca-ortega et al., Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy*, Critical Care Medicine, vol.35, issue.8, pp.1888-95, 2007.
DOI : 10.1097/01.CCM.0000275389.31974.22

S. Park, H. Park, S. Moon, K. Park, Y. Chong et al., Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosapneumonia, BMC Infectious Diseases, vol.61, issue.6, p.308, 2012.
DOI : 10.1016/j.jclinepi.2007.11.007

L. Deconinck, A. Meybeck, P. Patoz, N. Van-grunderbeeck, N. Boussekey et al., Infectious Diseases, vol.49, issue.5, pp.396-404, 2017.
DOI : 10.1016/j.jinf.2008.02.012

L. Ferná-ndez-barat, M. Ferrer, D. Rosa, F. Gabarrú-s, A. Esperatti et al., Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance, Journal of Infection, vol.74, issue.2, pp.142-52, 2017.
DOI : 10.1016/j.jinf.2016.11.008

K. Vardakas, G. Tansarli, I. Bliziotis, and M. Falagas, ??-Lactam plus aminoglycoside or fluoroquinolone combination versus ??-lactam monotherapy for Pseudomonas aeruginosa infections: A meta-analysis, International Journal of Antimicrobial Agents, vol.41, issue.4, pp.301-311, 2013.
DOI : 10.1016/j.ijantimicag.2012.12.006

A. Kumar, N. Safdar, S. Kethireddy, and D. Chateau, A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study, Critical Care Medicine, vol.38, issue.8, pp.1651-64, 2010.
DOI : 10.1097/CCM.0b013e3181e96b91

J. Kim, J. Chung, S. Choi, H. Jang, S. Hong et al., Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial, Critical Care, vol.16, issue.1, p.28, 2012.
DOI : 10.1016/j.ijheh.2008.07.001

M. Kollef, L. Morrow, M. Niederman, K. Leeper, A. Anzueto et al., Clinical Characteristics and Treatment Patterns Among Patients With Ventilator-Associated Pneumonia, Chest, vol.129, issue.5, pp.1210-1218, 2006.
DOI : 10.1378/chest.129.5.1210

Z. Athanassa, I. Siempos, and M. Falagas, Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review, European Respiratory Journal, vol.31, issue.3, pp.625-657, 2008.
DOI : 10.1183/09031936.00081007

A. Shorr, A. Combes, M. Kollef, and J. Chastre, Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy, Critical Care Medicine, vol.34, issue.3, pp.700-706, 2006.
DOI : 10.1097/01.CCM.0000201885.57697.21

J. Rello, M. Ulldemolins, T. Lisboa, D. Koulenti, R. Mañ-ez et al., Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia, European Respiratory Journal, vol.37, issue.6, pp.1332-1341, 2011.
DOI : 10.1183/09031936.00093010

F. Santé-publique, Surveillance des infections nosocomiales en ré animation adulte, Ré seau REA-Raisin, France. Ré sultats 2015. Saint-Maurice: Santé publique France, p.66, 2017.

B. Silva, R. Andriolo, A. Atallah, and R. Salomão, De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock, Cochrane Database of Systematic Reviews, vol.12, issue.6, p.7934, 2013.
DOI : 10.1002/14651858.CD007934.pub2

M. Leone, C. Bechis, K. Baumstarck, J. Lefrant, J. Albanè-se et al., De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial, Intensive Care Medicine, vol.17, issue.8 Suppl, pp.1399-408, 2014.
DOI : 10.1186/cc12849
URL : https://hal.archives-ouvertes.fr/hal-01945691

J. Garnacho-montero, A. Gutié-rrez-pizarraya, A. Escoresca-ortega, Y. Corcia-palomo, E. Ferná-ndez-delgado et al., De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock, Intensive Care Medicine, vol.53, issue.Suppl 2, pp.32-40, 2014.
DOI : 10.1093/cid/cir475

E. Giantsou, N. Liratzopoulos, E. Efraimidou, M. Panopoulou, E. Alepopoulou et al., De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate, Intensive Care Medicine, vol.122, issue.6, pp.1533-1573, 2007.
DOI : 10.1164/ajrccm.165.7.2105078

M. Joung, J. Lee, S. Moon, H. Cheong, E. Joo et al., Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia, Critical Care, vol.15, issue.2, p.79, 2011.
DOI : 10.1007/s101560070001

J. Morel, J. Casoetto, R. Jospé, G. Aubert, R. Terrana et al., De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit, Critical Care, vol.14, issue.6, p.225, 2010.
DOI : 10.1186/cc9373

F. Khasawneh, A. Karim, T. Mahmood, S. Ahmed, S. Jaffri et al., Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia, Infection and Drug Resistance, vol.7, pp.177-82, 2014.
DOI : 10.2147/IDR.S65928

S. Eachempati, L. Hydo, J. Shou, and P. Barie, Does De-Escalation of Antibiotic Therapy for Ventilator-Associated Pneumonia Affect the Likelihood of Recurrent Pneumonia or Mortality in Critically Ill Surgical Patients?, The Journal of Trauma: Injury, Infection, and Critical Care, vol.66, issue.5, pp.1343-1351, 2009.
DOI : 10.1097/TA.0b013e31819dca4e

A. Joffe, J. Muscedere, J. Marshall, Y. Su, and D. Heyland, The safety of targeted antibiotic therapy for ventilator-associated pneumonia: A multicenter observational study, Journal of Critical Care, vol.23, issue.1, pp.82-90, 2008.
DOI : 10.1016/j.jcrc.2007.12.006

R. Pugh, C. Grant, R. Cooke, and G. Dempsey, Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults, Cochrane Database Syst Rev, vol.8, p.7577, 2015.

G. Dimopoulos, G. Poulakou, I. Pneumatikos, A. Armaganidis, M. Kollef et al., Short- vs Long-Duration Antibiotic Regimens for Ventilator-Associated Pneumonia, Chest, vol.144, issue.6, pp.1759-67, 2013.
DOI : 10.1378/chest.13-0076

J. Chastre, M. Wolff, J. Fagon, S. Chevret, F. Thomas et al., Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults, JAMA, vol.290, issue.19, pp.2588-98, 2003.
DOI : 10.1001/jama.290.19.2588

M. Kollef, J. Chastre, M. Clavel, M. Restrepo, B. Michiels et al., A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia, Critical Care, vol.16, issue.6, p.218, 2012.
DOI : 10.1164/rccm.201102-0349OC

G. Capellier, H. Mockly, C. Charpentier, D. Annane, G. Blasco et al., Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment, PLoS ONE, vol.7, issue.8, p.41290, 2012.
DOI : 10.1371/journal.pone.0041290.s002
URL : https://hal.archives-ouvertes.fr/hal-00821494

F. Hassen, M. Ayed, S. , B. S. Ali, H. Gharbi et al., Dur??e de l???antibioth??rapie lors du traitement des pneumopathies acquises sous ventilation m??canique??: comparaison entre sept jours et dix jours. ??tude pilote, Annales Fran??aises d'Anesth??sie et de R??animation, vol.28, issue.1, pp.16-23, 2009.
DOI : 10.1016/j.annfar.2008.10.021

N. Singh, P. Rogers, C. Atwood, M. Wagener, and V. Yu, Short-course Empiric Antibiotic Therapy for Patients with Pulmonary Infiltrates in the Intensive Care Unit, American Journal of Respiratory and Critical Care Medicine, vol.11, issue.2, pp.505-516, 2000.
DOI : 10.1093/clinids/24.2.211

A. Hallal, S. Cohn, N. Namias, F. Habib, G. Baracco et al., Aerosolized Tobramycin in The Treatment of Ventilator-Associated Pneumonia: A Pilot Study, Surgical Infections, vol.8, issue.1, pp.73-82, 2007.
DOI : 10.1089/sur.2006.051

M. Kollef, J. Ricard, D. Roux, B. Francois, E. Ischaki et al., A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia, Chest, vol.151, issue.6, pp.12-369262463, 2016.
DOI : 10.1016/j.chest.2016.11.026

L. Palmer and G. Smaldone, Reduction of Bacterial Resistance with Inhaled Antibiotics in the Intensive Care Unit, American Journal of Respiratory and Critical Care Medicine, vol.135, issue.10, pp.1225-1258, 2014.
DOI : 10.1164/ajrccm.162.5.9908088

L. Palmer, G. Smaldone, J. Chen, D. Baram, T. Duan et al., Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit*, Critical Care Medicine, vol.36, issue.7, pp.2008-2021, 2008.
DOI : 10.1097/CCM.0b013e31817c0f9e

Q. Lu, Y. J. Liu, Z. Gutierrez, C. Aymard, G. Rouby et al., American Journal of Respiratory and Critical Care Medicine, vol.43, issue.1, pp.106-121, 2011.
DOI : 10.1086/379825

M. Niederman, J. Chastre, K. Corkery, J. Fink, C. Luyt et al., BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia, Intensive Care Medicine, vol.13, issue.Suppl 1, pp.263-71, 2012.
DOI : 10.1186/cc8206

P. Rattanaumpawan, J. Lorsutthitham, P. Ungprasert, N. Angkasekwinai, and V. Thamlikitkul, Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria, Journal of Antimicrobial Chemotherapy, vol.50, issue.6, pp.2645-2654, 2010.
DOI : 10.1128/AAC.00035-06

A. Valachis, G. Samonis, and D. Kofteridis, The Role of Aerosolized Colistin in the Treatment of Ventilator-Associated Pneumonia, Critical Care Medicine, vol.43, issue.3, pp.527-560, 2015.
DOI : 10.1097/CCM.0000000000000771

F. Zampieri, N. Jr, A. Gusmao-flores, D. Taniguchi, L. Torres et al., Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis, Critical Care, vol.5, issue.1, p.150, 2015.
DOI : 10.1186/1471-2288-5-6

Q. Lu, R. Luo, L. Bodin, J. Yang, N. Zahr et al., Efficacy of High-dose Nebulized Colistin in Ventilator-associated Pneumonia Caused by Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, Anesthesiology, vol.117, issue.6, pp.1335-1382, 2012.
DOI : 10.1097/ALN.0b013e31827515de

C. Solé-lleonart, J. Rouby, S. Blot, G. Poulakou, J. Chastre et al., Nebulization of Antiinfective Agents in Invasively Mechanically Ventilated Adults, Anesthesiology, vol.126, issue.5, pp.890-908, 2017.
DOI : 10.1097/ALN.0000000000001570

E. Boselli, D. Breilh, S. Djabarouti, C. Guillaume, T. Rimmelé et al., Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients, Intensive Care Medicine, vol.270, issue.9, pp.1519-1542, 2007.
DOI : 10.1016/S0140-6736(86)90837-8

A. Carcas, J. García-satué, P. Zapater, and J. Frías-iniesta, Tobramycin penetration into epithelial lining fluid of patients with pneumonia, Clinical Pharmacology & Therapeutics, vol.65, issue.3, pp.245-50, 1999.
DOI : 10.1016/S0009-9236(99)70103-7

C. Luyt, M. Clavel, K. Guntupalli, J. Johannigman, J. Kennedy et al., Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia, Critical Care, vol.13, issue.6, p.200, 2009.
DOI : 10.1186/cc8206

I. Goldstein, F. Wallet, A. Nicolas-robin, F. Ferrari, C. Marquette et al., Pneumonia in Ventilated Piglets, American Journal of Respiratory and Critical Care Medicine, vol.166, issue.10, pp.1375-81, 2002.
DOI : 10.1128/AAC.8.5.585

I. Goldstein, F. Wallet, J. Robert, M. Becquemin, C. Marquette et al., Lung Tissue Concentrations of Nebulized Amikacin during Mechanical Ventilation in Piglets with Healthy Lungs, American Journal of Respiratory and Critical Care Medicine, vol.127, issue.2, pp.171-176, 2002.
DOI : 10.1128/AAC.39.1.264

Q. Lu, C. Girardi, M. Zhang, B. Bouhemad, K. Louchahi et al., Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa, Intensive Care Medicine, vol.102, issue.suppl 1, pp.1147-55, 2010.
DOI : 10.1161/01.RES.55.2.155

P. Kruger, M. Bailey, R. Bellomo, D. Cooper, M. Harward et al., ANZ- STATInS Investigators ? ANZICS Clinical Trials Group. A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis

, Am J Respir Crit Care Med, vol.187, issue.7, pp.743-50, 2013.

P. Kruger, M. Harward, M. Jones, C. Joyce, K. Kostner et al., Continuation of Statin Therapy in Patients with Presumed Infection, American Journal of Respiratory and Critical Care Medicine, vol.183, issue.6, pp.774-81, 2011.
DOI : 10.1146/annurev.pharmtox.45.120403.095748

V. Novack, M. Eisinger, A. Frenkel, M. Terblanche, N. Adhikari et al., The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial, Intensive Care Medicine, vol.5, issue.7, pp.1255-60, 2009.
DOI : 10.1097/01.CCM.0000145229.59014.6C

L. Papazian, A. Roch, P. Charles, C. Penot-ragon, G. Perrin et al., Effect of Statin Therapy on Mortality in Patients With Ventilator-Associated Pneumonia, JAMA, vol.310, issue.16, pp.1692-700, 2013.
DOI : 10.1001/jama.2013.280031

J. Patel, C. Snaith, D. Thickett, L. Linhartova, T. Melody et al., Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial), Critical Care, vol.16, issue.6, p.231, 2012.
DOI : 10.1097/CCM.0b013e3182037a8e

Y. Wan, T. Sun, Q. Kan, F. Guan, and S. Zhang, Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies, Critical Care, vol.18, issue.2, p.71, 2014.
DOI : 10.1164/rccm.200810-1584OC

R. Bruyere, C. Vigneron, S. Prin, A. Pechinot, J. Quenot et al., Impact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: an observational study, Critical Care, vol.18, issue.2, p.83, 2014.
DOI : 10.1164/rccm.200406-746OC

Y. Que, H. Lazar, M. Wolff, B. François, P. Laterre et al., Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia, European Journal of Clinical Microbiology & Infectious Diseases, vol.31, issue.3, pp.1861-1868, 2014.
DOI : 10.1097/01.CCM.0000055380.86458.1E

Q. Lu, J. Rouby, P. Laterre, P. Eggimann, A. Dugard et al., Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia, Journal of Antimicrobial Chemotherapy, vol.66, issue.4, pp.1110-1116, 2011.
DOI : 10.1097/TA.0b013e31819a06e0